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Thyroid hormones (THs) and oestrogens are crucial in the regulation of 
cerebellar development. TH receptors (TRs) mediate these hormone effects and 
are regulated by both hormone families. We reported earlier that THs and oestra-
diol (E2) determine TR levels in cerebellar cell culture. Here we demonstrate the 
effects of low concentrations (10–10 M) of the endocrine disruptor (ED) bisphenol 
A (BPA) on the hormonal (THs, E2) regulation of TRα,β in rat cerebellar cell cul-
ture. Primary cerebellar cell cultures, glia-containing and glia-destroyed, were 
treated with BPA or a combination of BPA and E2 and/or THs. Oestrogen recep-
tor and TH receptor mRNA and protein levels were determined by real-time 
qPCR and Western blot techniques. The results show that BPA alone decreases, 
while BPA in combination with THs and/or E2 increases TR mRNA expression. 
In contrast, BPA alone increased receptor protein expressions, but did not further 
increase them in combination with THs and/or E2. The modulatory effects of BPA 
were mediated by the glia; however, the degree of changes also depended on the 
specific hormone ligand used. The results signify the importance of the regulatory 
mechanisms interposed between transcription and translation and raise the possi-
bility that BPA could act to influence nuclear hormone receptor levels independ-
ently of ligand–receptor interaction. 
Key words: Endocrine disruptors, thyroid receptor, transcription, transla-
tion, bisphenol A, rat cerebellum 
Thyroid hormones (THs) and oestrogens (mostly 17β-oestradiol, E2) play 
critical roles in the regulation of central nervous system (CNS) development, in-
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cluding the cerebellum. Effects of these hormones are mediated by numerous 
mechanisms, including, but most probably not limited to, cognate receptors (oes-
trogen receptors alpha and beta [ERα,β] and TH receptors alpha and beta 
[TRα,β]) (Belcher and Zsarnovszky, 2001; Fan et al., 2010), membrane-linked 
ligand-receptor complexes (Belcher, 2008; Leonard, 2008) and crosstalk between 
genomic and/or non-genomic E2- and TH-activated intracellular signalling path-
ways (Vasudevan et al., 2001; Zhao et al., 2005). Previously we demonstrated 
that E2 and THs alone or in combination determine TRα,β and ERβ mRNA and 
protein expression levels in primary cerebellar cell cultures (Scalise et al., 2012). 
In addition to hormone effects, we also showed that the astroglia (glia) may be an 
additional site of these actions. Based on the available literature and our studies, 
endocrine disruptor- (ED) induced disturbance of the physiological synchrony 
between E2 and THs during cerebellar development could be more pervasive and 
far-reaching than currently appreciated, and merits investigation (Somogyi et al., 
2011). 
Oestrogenic ED chemicals, such as phytoestrogens or environmental pol-
lutants are selective ER modulators and can act as agonists or antagonists of the 
hormones in question. During development, EDs can influence normal hormonal 
homeostasis and lead to immediate and/or lifelong consequences (e.g., Zsar-
novszky et al., 2007; Miodovnik et al., 2014). With regard to ED effects in the 
cerebellum, we have previously shown that bisphenol A (BPA) rapidly activates 
ERK1/2 in primary cerebellar cell cultures (Wong et al., 2003) and also after in-
jection of BPA into the cerebella of newborn rat pups (Zsarnovszky et al., 2005). 
These effects were concentration dependent, with a U-shaped concentration–
response curve, which could indicate compound actions of BPA. In support of 
these findings, Mathisen et al. (2013) described that perinatal BPA exposure in-
creased Pax6 (transcription factor playing a role in granule cell development and 
migration) in newborn mice cerebella and in cerebellar cell cultures. In the hip-
pocampus, BPA modulated dendritic morphogenesis via effects on ER (Xu et al., 
2014). Likewise, BPA also promoted dendritic growth in maturing cerebellar 
Purkinje cells (Shikimi et al., 2004). This is consonant with our previous results 
(Wong et al., 2003; Zsarnovszky et al., 2005). 
In addition, BPA can alter thyroid-specific gene expression (Gentilcore et 
al., 2013) and functions (Zoeller et al., 2005; Iwamuro et al., 2006; Delfosse et 
al., 2014). Our studies indicated that the ratio of THs to E2 in the CNS is critical 
for the regulation of nuclear receptor expression (Scalise et al., 2012). 
While a growing body of evidence indicates that EDs, including BPA, in-
terfere with CNS development, the exact mode of BPA action, and how it alters 
TR expression levels, is not clear. In the present study we examined to what ex-
tent BPA alone or in combination with THs and/or E2 alters TRα,β mRNA and 
protein expression levels in primary cerebellar cell cultures. We also examined 
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whether the glia could modulate hormone and/or BPA effects on TR mRNA and 
protein expression levels. 
 
Materials and methods 
Hormones and BPA were obtained from Sigma Aldrich Ltd., Hungary. 
Animals 
Since neither previous studies nor our own results indicated sex differences 
in the developing rat cerebellum in any of the parameters examined in this study, 
both male and female Sprague-Dawley rat pups (body weight: 18–20 g) were 
used. Timed pregnant Sprague-Dawley rats (Charles River Laboratories, Ger-
many; n = 60) were obtained from the vendor at least four days before they gave 
birth. Animals were kept under standard laboratory conditions (temperature: 24–
25 °C; humidity: 55–60%; room ventilation rate: 17 air changes per hour, with 
the animals protected from draughts; noise reduced to the possible minimum in 
the human hearing range, as well as in the ultrasonic range), with tap water and 
regular rat chow ad libitum in a 12-h light, 12-h dark cycle. The date of the pups’ 
birth was considered as postnatal day 0 (P0). Animals were used for granule cell 
preparation on their P7 (n = 576, i.e., n = 6 per each treatment group).  
Following the guidelines established by the National Institutes of Health 
(NIH), the use of animals was approved by the Animal Welfare Board at Szent 
István University, Faculty of Veterinary Science and were approved by the re-
gional animal welfare authority (registry no.: XIV-I-001/2201-4/2012). 
Preparation of primary cerebellar cell cultures 
Primary cerebellar cultures were prepared as described earlier (Wong et 
al., 2001) with modifications, as follows. Animals were sacrificed by quick de-
capitation and the cerebella removed. Cell cultures were prepared without enzy-
matic treatment and were maintained in serum- and steroid-free conditions as 
previously described (Wong et al., 2001). Cerebellar cell suspensions were di-
luted with culture medium to obtain 2300–2700 granule cells/mm2 prior to test-
ing. Cerebella of rat pups were seeded into separate culture dishes (i.e., 6 dishes 
per treatment, n = 6). Astroglia in the cultures was identified by immunohisto-
chemical labelling for the specific astroglia marker glial fibrillary acidic protein 
(GFAP), as we previously described and illustrated (Scalise et al., 2012).  
Treatments 
For analysis of mature (post-mitotic) primary cerebellar granule cells in a 
glia-destroyed environment, a final concentration of 10–5 M cytosine β-D-
arabinofuranoside (AraC; Sigma Aldrich Ltd., Hungary; Cat. # 147-94-4) was 
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added 24 h after seeding to inhibit the growth and proliferation of non-neuronal 
cells (Glia– cultures). In contrast, no AraC was added to the media for analysis 
of neurones grown in a glia-containing environment (Glia+ cultures). The presence 
or absence of glia in the cultures was verified and illustrated as shown earlier 
(Scalise et al., 2012). Cultures were treated with either of the following hor-
mones (at physiologically relevant concentrations, as described below) and/or 
bisphenol A, 7 days after seeding and 6 h (for qPCR) or 18 h (for Western blot) 
before harvesting: 17β-oestradiol (E2, 1.16x10–10 M, Sigma Aldrich Ltd., Hun-
gary, Cat. # E2758); 3,3’,5-triiodo-L-thyronine (T3, 0.92 × 10–9 M, Sigma Al-
drich Ltd., Hungary; Cat. # T2877); L-thyroxine (T4, 65 × 10–9 M, Sigma Al-
drich Ltd., Hungary; Cat # T1775); E2 + T3 or E2 + T4 (at concentrations de-
scribed above); bisphenol A (BPA, 10–10 M, Sigma Aldrich Ltd., Hungary; Cat # 
A239658); BPA + E2; BPA + T3; BPA + E2 + T3; BPA + T4; BPA + E2 + T4; 
the latter BPA-containing combined treatments were carried out in both Glia– 
and Glia+ groups. Cultures without hormone treatments were included in both 
Glia+ and Glia– groups (non-treated control, ntC). The applied concentration of 
BPA (10–10 M) was chosen based on our previous experiments (Wong et al., 
2003) as follows: The biphasic effects of E2 and BPA at the low concentration 
range (10–12 to 10–9 M) were assumed to act at two binding sites, one stimulatory 
with a high affinity and one with a lower affinity that inhibits the effect of the 
first site. Based on the observed similarity in effect at each concentration it was 
also assumed that neither of the two sites distinguishes between E2 and BPA. 
Thus, data points were fit with the Hill-type equation: 
 
where [C] is the concentration of the ligand. A best fit of the equation to 
the data resulted from setting the maximum effect of the stimulatory site (maxi-
mal stimulation) at 110%, with resulting values of 0.4 and 2 obtained for the 
stimulatory and the inhibitory Hill coefficients (H1 and H2), respectively. Under 
these conditions, EC50Stim and EC50Inhib were determined as 8 × 10–12 M and 4 × 
10–9 M, respectively. 
Western blot studies 
Cell harvesting was performed as described by Wong et al. (2001). Samples 
were homogenized in (in mM) 20 Tris [(Tris-(hydroxymethyl)aminomethane, Re-
anal Cat. # 34780-1-99-38) pH 7.6, 150 NaCl (Sigma Aldrich Ltd., Hungary, 
Cat. # S5886), 1 PMSF (Sigma Aldrich Ltd., Hungary, Cat. # P7626), 1 EGTA 
(Sigma Aldrich Ltd., Hungary, Cat. # E3889), 1 EDTA (Reanal-Ker Ltd., Hun-
gary, Cat. # 19012-1-38), 2.5 sodium pyrophosphate (Sigma Aldrich Ltd., Hun-
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gary, Cat. # P8010), 1-β-glycerol phosphate (Sigma Aldrich Ltd., Hungary, Cat, 
# G9891), and 1 Na3VO4 (Sigma Aldrich Ltd., Hungary, Cat. # S6508) plus 
1 mg/ml Pefabloc (Fluka, Cat. # 76307), 10 μg/ml leupeptin (Sigma Aldrich Ltd., 
Hungary, Cat. # L2884), 10 μg/ml pepstatin (Sigma Aldrich Ltd., Hungary, Cat. 
# P5318), 1 μg/ml aprotinin (Sigma Aldrich Ltd., Hungary, Cat. # A3428), 1% 
Triton X-100 (Sigma Aldrich Ltd., Hungary, Cat. # T8787), and 0.05% sodium 
deoxycholate (Sigma Aldrich Ltd., Hungary, Cat. # D6750). Homogenates were 
sonicated for 5 sec a total of 5 times and cleared by centrifugation at 14,000 × g 
for 1 min at 2 °C. Protein concentrations were determined with a BCA protein 
assay kit (Pierce, Rockford, IL). Western blotting and densitometric analysis were 
performed by standard protocols (Wong et al., 2001); primary antibodies: anti-
thyroid hormone receptor alpha, Abnova PAB-11276, dilution: 1:1,000; anti-
thyroid hormone receptor beta, Abnova PAB-11277, dilution: 1:1000. Secondary 
antibodies: peroxidase labelled goat-anti rabbit IgG, Vector Laboratories, UK, Cat. 
# PI-1,000, dilution: 1:2,000; peroxidase-labelled horse-anti mouse IgG, Vector 
Laboratories, UK, Cat. # PI-2,000, dilution: 1:2,000). Immunoreactive bands 
were visualised onto preflashed X-ray film by enhanced chemiluminescence and 
analyzed by densitometric analysis. Optical densities were calculated as arbitrary 
units, normalised to the protein concentrations of samples, and to the ntC of 
Glia+. Results are presented as fold changes relative to the ntC of Glia+ cultures. 
All data that have been presented are representative of at least three independent 
experiments (n = 6 per treatment). 
Quantitative PCR measurements 
Total RNA was isolated from the cell samples using TRI Reagent (Invi-
trogen, Carlsbad, CA, USA, Cat. # RT111) according to the manufacturer’s in-
structions. Reverse transcription polymerase chain reaction was carried out fol-
lowing standard protocols. Primer sequences were as published by Billon et al. 
(2002) for TRα, and Kariv et al. (2003) for TRβ. Cellular gene expression was 
quantified by quantitative PCR reactions (qPCR; LightCycler 2.0, F. Hoffmann-
La Roche Ltd., Basel, Switzerland) using LightCycler DNA Master 
SYBRGReen I fluorescent dye (Hoffmann-La Roche Ltd., Basel, Switzerland, 
Cat. # 12015099001). Aliquots of cDNAs were dispensed according to the 
manufacturer’s instructions. QPCR cycles and controls were planned according 
to the manufacturer’s instructions and were optimised for each primer pair. Am-
plified products were identified by agarose gel electrophoresis, melting point and 
sequence analysis (Applied Biosystems ABI 3100 Genetic Analyzer, Agricul-
tural Biotechnology Centre, Gödöllő, Hungary). Real-time PCR threshold cycle 
(Ct) data were analysed using the REST-XL software version 2.0. The target Ct 
of each sample was normalized to the Ct of the reference (housekeeping) gene 
(rat cytoplasmic beta actin) in the same sample. Differences in the Ct values 
were converted into relative amounts of mRNA based on the assumption of am-
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plification efficiency = 2.0. Results are presented as fold changes relative to the 
ntC of Glia+ cultures (i.e., further normalised to the ntC of Glia+). 
Data analysis 
All data that have been presented are representative of at least three inde-
pendent measurements. Statistical analyses were conducted using Excel (Micro-
soft, Microsoft Co., Redmond, WA, USA) and GraphPad Prism version 4 
(GraphPad Software, San Diego, CA), by means of one-way ANOVA with 
Tukey’s multiple comparison test. The level of statistical significance in differ-





The results of hormone treatments were concordant with those we previ-
ously described (Scalise et al., 2012), so they will not be the major focus of this 
report; rather, these non-BPA-results are used as the reference base for the com-
parison between the effects of BPA alone and in combination with either E2 
and/or THs. 
In general, transcriptional activity was higher in Glia– cultures compared 
to ntC [Glia+] (Figs 1 and 3). Regardless of the glia, in BPA-treated cultures re-
ceptor mRNA levels were lower than in ntCs (Figs 1 and 3; columns A vs. B and 
M vs. N), however, combined treatment with BPA and either E2 or T3 resulted in 
increased receptor mRNA levels. 
Thyroid hormone receptor alpha (TRα) 
TRα mRNA: Glia+ vs. Glia– (Fig. 1). Non-treated controls of Glia+ and 
Glia– significantly differed from each other, with higher TRα mRNA values in 
Glia– cultures. Such a difference was found between BPA [Glia+] and BPA 
[Glia–] as well. With respect to combined treatment groups, with the exception 
of T3 + BPA, an opposite effect was evident: TRα mRNA expression was lower 
in E2 + BPA, T4 + BPA, E2 + T3 + BPA and E2 + T4 + BPA cultures of Glia– 
than of Glia+. 
TRα protein: Glia+ vs. Glia– (Fig. 2). In Glia+ cultures (Fig. 2 columns 
A–L), TRα receptor protein expression was maintained at significantly higher 
level than the ntC in all treatment groups, with the exception of E2 treatment. In 
contrast, in Glia– cultures, differences were found between groups treated with 
hormones only and those exposed to BPA as well. In Glia–, BPA treatment alone 
resulted in the expression of just as much receptor protein as BPA in combina-
tion with any of the hormones used. 
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Fig. 1. TRα mRNA expression in primary cerebellar cell cultures treated with BPA, E2, TH or a 
combination of these substances. X axis shows experimental groups; Y axis shows fold changes 
versus non-treated control (ntC) of Glia+. In Glia+ cultures, BPA decreased TRα mRNA expres-
sion compared to the ntC and resulted in mRNA levels lower than after E2 or TH treatment. In 
Glia– cultures, however, TRα mRNA expressions were less different between the BPA- and TH-
treated groups. It is suggested that the glia may mediate BPA effects on transcription. All data that 
have been presented are representative of at least three independent measurements. Data show 
mean values ± SEM. Statistical analyses were conducted using one-way ANOVA with Tukey’s 
multiple comparison test (n = 6). The level of statistical significance in differences between ex-
perimental groups is P < 0.05. Smaller size letters above the columns indicate significant differ-
ences from columns labelled with larger size letters 
Thyroid hormone receptor beta (TRβ)  
TRβ mRNA: Glia+ vs. Glia– (Fig. 3). Differences between the members of 
the Glia+ and Glia– showed comparable trends, although distinct differences be-
tween analogous treatment subgroups may be remarkable and resemble, in many 
respects, our TRα-related findings. Specifically, two exceptions were found from 
the above-stated phenomenon: (1) TRβ mRNA expression in T3 + BPA cultures 
was considerably higher in Glia– compared to Glia+ cultures; (2) in E2 + T3 + 
BPA treatment groups, TRβ mRNA was significantly and prominently higher in 
Glia+ than in Glia–. 
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Fig. 2. TRα protein expression in primary cerebellar cell cultures treated with BPA, E2, TH or a 
combination of these substances. X axis shows experimental groups; Y axis shows fold changes 
versus non-treated control (ntC) of Glia+. In the presence of glia (Glia+), E2 alone did not cause a 
significant change compared to the ntC. In glia-destroyed environment (Glia–), significant differ-
ences were detected after BPA exposure compared to hormone-only treated cultures. All data that 
have been presented are representative of at least three independent measurements. Data show 
mean values ± SEM. Statistical analyses were conducted using one-way ANOVA with Tukey’s 
multiple comparison test (n = 6). The level of statistical significance in differences between ex-
perimental groups is P < 0.05. Smaller size letters above the columns indicate significant differ-
ences from columns labelled with larger size letters 
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Fig. 3. TRβ mRNA expression in primary cerebellar cell cultures treated with BPA, E2, TH or a 
combination of these substances. X axis shows experimental groups; Y axis shows fold changes 
versus non-treated control (ntC) of Glia+. E2 and E2 + BPA effects do not seem to be glia-
dependent. However, when T3 was also added to the culture medium, significant differences were 
found between Glia+ and Glia– cultures. In Glia+ cultures, co-exposure of the cells to BPA and E2 
or E2+T3 resulted in a nearly three-magnitude increase in TRβ transcription. All data that have 
been presented are representative of at least three independent measurements. Data show mean 
values ± SEM. Statistical analyses were conducted using one-way ANOVA with Tukey’s multiple 
comparison test (n = 6). The level of statistical significance in differences between experimental 
groups is P < 0.05. Smaller size letters above the columns indicate significant differences from col-
umns labelled with larger size letters 
 
TRβ protein: Glia+ vs. Glia– (Fig. 4). TRβ protein expression measured 
in analogous subgroups of Glia+ and Glia– were relatively close to each other. 
TRβ protein expression levels were about twice as high in groups treated with 
BPA or BPA as well, than in cultures not treated with BPA, regardless of the 
presence or absence of glia. With respect to BPA exposure, clear glia effect on 
TRβ protein expression was only observed in analogous E2 + BPA and E2 + T4 + 
BPA groups. 
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Fig. 4. TRβ protein expression in primary cerebellar cell cultures treated with BPA, E2, TH or a 
combination of these substances. X axis shows experimental groups; Y axis shows fold changes 
versus non-treated control (ntC) of Glia+. Receptor protein expression levels were about twice as 
high in groups treated with BPA or BPA as well, than in cultures not treated with BPA, regardless 
of the presence or absence of glia. Clear glia effect was only observed in analogous E2 + BPA 
(columns D vs. P) and E2 + T4 + BPA groups (columns L vs. X). All data that have been presented 
are representative of at least three independent measurements. Data show mean values ± SEM. Sta-
tistical analyses were conducted using one-way ANOVA with Tukey’s multiple comparison test 
(n = 6). The level of statistical significance in differences between experimental groups is P < 0.05. 
Smaller size letters above the columns indicate significant differences from columns labelled with 




The primary cerebellar cell culture has been extensively used for the study 
of cellular responses to various experimental cues. A question that we should ad-
dress is with regard to the effect of glia in the adjustment of TR expression. In 
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the present study, we compare endocrine effects in glia-containing versus glia-
destroyed cultures. While differences between these groups is clearly the result 
of the presence or absence of glia, differences between treatment groups in Glia– 
cultures carry the enigma of the share of glial TR levels in the entire cultured cell 
population. Since, however, granule neurones extremely outnumber sporadic and 
rudimentary glial cells in these cultures, it seems to be safe to interpret the treat-
ment effects as if they were only exerted by neurones. 
Receptor mRNA levels 
Under in vitro circumstances it is especially interesting that BPA alone 
suppresses TR mRNA expression. This is supported by the findings of Sheng et 
al. (2012); however, earlier data also suggest that the suppressing effect of BPA 
on TRs may only be temporary, and symptoms that emerge later in life resulting 
from perinatal exposure to BPA may develop on the grounds of BPA-linked 
mechanisms indirectly (Xu et al., 2007). The observation that ntC values in Glia– 
cultures superseded those measured in ntC Glia+ suggests that the glia plays a 
role in the regulation of transcription, regardless of the type of receptor exam-
ined; even when cells were only treated with BPA alone, consequential decrease 
in TR transcription was more evident if the glia was present in the culture. While 
these observations are in concordance with previous results (Yamaguchi et al., 
2006; Fauquier et al., 2014), our data also show that the effects of BPA on TR 
transcription are multifactorial and, in addition, differ depending on the presence 
or the absence of glia. 
In contrast to the suppressing effect of BPA on receptor mRNA expression, 
the combination of BPA with any of the hormones provoked remarkably high 
transcriptional activity, regardless of the hormone used or the receptor examined. 
Such a robust ED effect has been reported earlier (Zhang et al., 2013), yet, this 
finding should still be alarming. To our knowledge, currently there is no explana-
tion for this massive upregulation, although it is likely that the ability of BPA to 
act on TRs plays a role in the potentiation of transcription (Zoeller, 2005). 
Receptor protein levels 
It was generally observed that the effects of BPA or BPA in combination 
with E2 and/or THs on translation (receptor protein expression) were less promi-
nent than those found with regard to mRNA expression. Since the cellular effects 
of hormones are mostly mediated by their cognate receptors, this observation can 
explain why the biological effects of BPA-exposure could have remained 
masked or even unrecognised for a long time in spite of the dramatically in-
creased transcriptional activity. Several studies suggested that exposure to EDs 
early in life leads to altered CNS development and functional deficiencies later in 
adulthood (Mathisen et al., 2013). The present results suggest that the final, al-
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tered outcome of hormonal signalling during ED exposure may only partly ac-
count for those anomalies, since the increased material and energy consumption 
by CNS cells in the process of enhanced transcription could also lead to energy-
deficient intracellular conditions that could be, at least in part, responsible for 
developmental deficiencies. This idea is consonant with the report of Nakagawa 
and Tayama (2000) that BPA toxicity caused a decrease in cellular ATP levels in 
hepatocytes. 
The unproportional ED effects in transcription versus translation also indi-
cate that regulatory mechanisms, interposed between transcription and transla-
tion, such as microRNA regulation, may also be affected by EDs, as indicated by 
Avissar-Whiting et al. (2010) and Tilghman et al. (2012). These mechanisms ap-
parently play a crucial role in buffering ED effects downstream of transcription. 
This idea not only warrants further research of these mechanisms, but also shows 
that the potential vulnerability of such interposed regulatory mechanisms may 
determine the severity of ED effects. 
Thyroid hormone receptor alpha (TRα) 
TRα mRNA: Glia+ vs. Glia– (Fig. 1). While differences between Glia+ 
and Glia– show comparable trends, it is noteworthy that in Glia+, BPA treatment 
alone resulted in lower TRα mRNA expression than E2 treatment alone, in con-
trast to the opposite findings in Glia–. Whether or not differences between treat-
ment groups compared to their respective ntC followed similar trends (changes 
relative to each other), results indicate that the differences are due to glial effects. 
One possible mechanism underlying the afore-mentioned idea is that the glia 
may mediate BPA effects on the level of transcription in a T3-dependent manner, 
which is likely due to the ability of astroglia to convert T4 to T3 through deiodi-
nation (Leonard, 1988). 
TRα protein: Glia+ vs. Glia– (Fig. 2). In Glia+, TRα receptor protein ex-
pression nearly doubled when cultures were exposed to any of the ligands used, 
with the exception of E2. Thus, the potency of BPA, as a known oestrogenic 
chemical, to influence TRα expression more than E2 underlines the importance of 
BPA to be considered as a general nuclear receptor modulator, rather than just a 
chemical with oestrogenic or thyroid effect. 
In Glia–, significant differences were found between groups treated with 
the hormones only and those exposed to BPA as well. This observation suggests 
that in the presence of glia, THs must be present for the maintenance of the 
afore-mentioned double levels of TRα protein expression (compared to ntC 
[Glia+]), and that under such circumstances BPA does not further increase the 
TH-regulated TRα expression. The finding that in Glia– cultures these twofold 
ntC values were only detected if BPA was present alone or in combination with 
the hormones indicates that in neurones of Glia–, BPA (but not the hormones) 
determined the actual TRα protein expression values. 
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TRα mRNA vs. TRα protein (Figs 1 and 2). The seemingly ligand-
independent receptor protein expression levels were based on highly ligand-
dependent transcriptional activity, especially in cultures treated with BPA or 
BPA in combination with any of the hormones. In Glia+, with the exception of 
the ntC and the E2 group, TRα protein expression levels were comparable (no 
significant differences), but were twofold compared to ntC. This phenomenon 
means that these cell populations could either not produce more TRα protein (be-
cause of their limited capacity or the activation of some down-regulating mecha-
nism), or the increased TRα expression levels after treatments were necessary for 
the maintenance of survival under the applied experimental conditions. It is also 
possible that robust increases in transcription (e.g., in Glia+: E2 + BPA, T3 + 
BPA, T4 + BPA and E2 + T3/T4 +BPA) may potentially exhaust cellular energy 
resources, thereby influencing other energy-dependent cellular processes as well. 
Based on the disproportionality between transcription and translation, it can 
be speculated that one of the cellular adaptation mechanisms may manifest in the 
form of a high degree of plasticity in transcription (and possibly linked mecha-
nisms, such as microRNA regulation, etc.) in order to maintain a relatively steady 
receptor protein expression. In fact, this idea may apply to our TRβ results as well. 
Thyroid hormone receptor beta (TRβ)  
TRβ mRNA: Glia+ vs. Glia– (Fig. 3). Differences between the members of 
Glia+ and Glia– resemble, in many respects, to those found with regard to TRα 
mRNA. Differences between respective treatment groups in Glia+ vs. Glia– sug-
gest that the mediating role of glia in the regulation of neuronal TRβ receptor ex-
pression is ligand dependent, and also indicate that this mediating activity, in ad-
dition to the mere glial presentation of T3 (after conversion of T4 to T3) to neu-
rones, contains additional functional element(s) as well, whose identification 
warrants further experiments. 
TRβ protein: Glia+ vs. Glia– (Fig. 4), mRNA vs. TRβ protein (Figs 3 and 4). 
The overall pattern of TRβ protein expression values may suggest that there is no 
glial contribution in the determination of the actual TRβ protein expression levels. 
It is, therefore, important to consider the role of glia in the regulation of TRβ 
transcription, since the simple examination of potential glia effects on TRβ pro-
tein expression would be misleading. 
It is also interesting that exposure to BPA, alone or in combination with 
any of the hormones used, leads to significantly elevated TRβ protein expression. 
This finding suggests that BPA could influence TRβ protein in a hormone 
ligand-independent manner, as also indicated with regard to TRα. Again, this 
conclusion would be misleading regarding the effects of BPA on TRβ protein 
expression; therefore, we conclude that BPA effects on transcription and transla-
tion should be comparatively evaluated to understand the complexity of BPA and 
maybe other ED effects on the regulation of TR expression. 
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Further considerations 
To the best of our knowledge, no clear definition of the differences be-
tween the functional roles of TRα and TRβ is available, most probably because 
of the usual co-activation of these receptors by their common ligands (Somogyi 
et al., 2011). There are, however, studies reporting on physiological functions 
partly regulated by either of these receptors. Based on knockout and knockin ex-
periments, TRα was found to influence cardiac functions, thermogenesis, haema-
topoiesis, and the maturation of intestines and bones (O’Shea et al., 2005; 
Plateroti et al., 2006). TRβ is crucial for normal, physiological endocrine and 
sensory functions such as those regulated by the hypothalamic–pituitary–thyroid 
axis, hepatic reactions to T3, behaviour, audition, colour sensation, and tactile 
senses (Amma et al., 2001; Ng et al., 2001; Flores-Morales et al., 2002; Abel et 
al., 2003; Esaki et al., 2003; Siesser et al., 2005). TRα and TRβ, however, can be 
co-expressed in the same tissues and can substitute for each other’s function to a 
certain extent (Gothe et al., 1999). Considering the latter potency of TRs allow 
us to reasonably suggest that one or more regulatory mechanisms interposed be-
tween transcription and translation is/are affected by BPA exposure. This idea is 
supported by reported alterations in microRNA expression in human placenta 
cells (Avissar-Whiting et al., 2010), MCF-7 breast cancer cells (Tilghman et al., 
2012) and ovine fetal ovary (Veiga-Lopez et al., 2013) after BPA exposure. 
We are aware that the in vitro conditions may substantially modify physio-
logical parameters. Yet, it is more than likely that the observed BPA effects, 
combined with numerous biologically linked mechanisms, also occur in vivo, 
with the notion that in vivo, TRβ expression is restricted to specific ontogenetic 
states and is highly tissue specific (Bradley et al., 1994). Altogether, this idea is 
consonant with results from animal models that have shown that hypothyroidism 
during critical periods of development causes a variety of abnormalities in the 
central nervous system (Pasquini and Adamo, 1994; Martinez-Galan et al., 1997; 
Simorangkir et al., 1997), and that TRα and TRβ can compensate for each 
other’s hypofunction. Finally, it should be noted that a growing body of evidence 
exists to show that BPA and other EDs increase intracellular reactive oxygen 
species and generate oxidative stress conditions in mitochondria and endoplas-
mic reticulum (Huc et al., 2012; Babu et al., 2013). 
The present results clearly indicate that BPA interferes with the normal 
hormonal regulation of TR expression and thereby may lead to yet unknown bio-
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